Who Supplies Budesonide? Top Manufacturers & Their Global Buyers
India accounts for a significant share of global Budesonide exports, with 275+ registered manufacturers shipping to buyers across 115+ countries — yet a handful of companies dominate the shipments. CIPLA LIMITED holds the largest share at 65.8% (export value: $125.4M). Close behind, SUN PHARMACEUTICAL INDUSTRIES LIMITED (3.3%, $6.3M). ZYDUS LIFESCIENCES LIMITED (1.0%, $1.9M). The Sankey diagram below maps every supplier's customer flow in detail. All figures are drawn from Indian Customs (DGFT) shipping bill records.
🏭 Market Analysis: Top Suppliers & Customer Networks
Comprehensive supplier network intelligence dashboard
Who Supplies Budesonide? Top Manufacturers & Their Buyers
Flow of Budesonide from leading Indian exporters to their key global customers
Supplier-Customer Network Analysis
Top Suppliers → Customer Networks
Budesonide Supplier Network — Key Market Intelligence
The Budesonide export market from India is led by CIPLA LIMITED, which alone commands a 65.8% share, shipping $125.4M worth of product across 1.1K shipments. The second-largest exporter, SUN PHARMACEUTICAL INDUSTRIES LIMITED, contributes $6.3M (3.3%) to the overall market. Combined, the top two suppliers alone account for 69.1% of all Budesonide exports, indicating a relatively concentrated supply base.
Across all 275 tracked manufacturers, the total Budesonide export value stands at $190.5M from 9.1K shipments. The market average shipment value is $20.8K. The single largest buyer relationship in terms of trade value is CIPLA USA INC UPS SUPPLY CHAIN SOL, receiving $74.7M worth of product.
The combined buyer network spans 15 named purchasing companies, including CIPLA USA INC UPS SUPPLY CHAIN SOL, ACINO PHARMACEUTICALS FZ LLC, BIOPHARM DISTRIBUTION SPA,, SUN PHARMACEUTICAL INDUSTRIES,INC.., TARO PHARMACEUTICALS INC., and 10 others. These buyers represent pharmaceutical manufacturers, distributors, hospital procurement groups, and generic drug producers operating across multiple continents.
Market Analysis: Top Suppliers & Their Customer Networks
1CIPLA LIMITED
CIPLA LIMITED is the first-largest Budesonide exporter from India, with a market share of 65.8% and a total export value of $125.4M across 1.1K shipments. Their average shipment value of $118.3K is above the market average of $20.8K, suggesting premium or bulk contract pricing.
CIPLA LIMITED serves 5 named buyers in our database. CIPLA USA INC UPS SUPPLY CHAIN SOL is the dominant customer, accounting for 59.6% of this supplier's tracked business. Top customers include:
• CIPLA USA INC UPS SUPPLY CHAIN SOL — $74.7M across 631 shipments (59.6% of this supplier's total exports)
• TO THE ORDER OF RIYA — $25.6M across 217 shipments (20.4% of this supplier's total exports)
• ACINO PHARMACEUTICALS FZ LLC — $12.9M across 109 shipments (10.3% of this supplier's total exports)
• BIOPHARM DISTRIBUTION SPA, — $7.5M across 63 shipments (6.0% of this supplier's total exports)
• CIPLA USA INC UPS SUPPLY CHAIN SOL — $4.6M across 39 shipments (3.7% of this supplier's total exports)
Key Insight: CIPLA LIMITED's per-shipment value of $118.3K is 468% above the market average of $20.8K, consistent with large-order contracts or value-added formulations.
2SUN PHARMACEUTICAL INDUSTRIES LIMITED
SUN PHARMACEUTICAL INDUSTRIES LIMITED is the second-largest Budesonide exporter from India, with a market share of 3.3% and a total export value of $6.3M across 166 shipments. Their average shipment value of $38.2K is above the market average of $20.8K, suggesting premium or bulk contract pricing.
SUN PHARMACEUTICAL INDUSTRIES LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• SUN PHARMACEUTICAL INDUSTRIES,INC.. — $3.0M across 79 shipments (47.4% of this supplier's total exports)
• SUN PHARMACEUTICAL INDUSTRIES,INC.. — $1.4M across 36 shipments (21.8% of this supplier's total exports)
• SUN PHARMACEUTICAL INDUSTRIES,INC.. — $965.3K across 25 shipments (15.2% of this supplier's total exports)
• TARO PHARMACEUTICALS INC., — $790.0K across 21 shipments (12.4% of this supplier's total exports)
• M/S. RANBAXY PHARMAC — $202.0K across 5 shipments (3.2% of this supplier's total exports)
Key Insight: SUN PHARMACEUTICAL INDUSTRIES LIMITED's per-shipment value of $38.2K is 84% above the market average of $20.8K, consistent with large-order contracts or value-added formulations.
3ZYDUS LIFESCIENCES LIMITED
ZYDUS LIFESCIENCES LIMITED is the third-largest Budesonide exporter from India, with a market share of 1.0% and a total export value of $1.9M across 78 shipments. Their average shipment value of $23.9K is above the market average of $20.8K, suggesting premium or bulk contract pricing.
ZYDUS LIFESCIENCES LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• XXDUSXXHARXXCEUXXCAL — $702.4K across 29 shipments (37.7% of this supplier's total exports)
• XXRTHXXAR XXALTXXARE — $477.1K across 20 shipments (25.6% of this supplier's total exports)
• ABACUS PHARMA (AFRIC — $262.4K across 11 shipments (14.1% of this supplier's total exports)
• SUNSHINE HEALTHCARE — $234.3K across 10 shipments (12.6% of this supplier's total exports)
• HAPHARCO J.S.C. BRAN — $185.4K across 8 shipments (10.0% of this supplier's total exports)
Key Insight: ZYDUS LIFESCIENCES LIMITED's per-shipment value of $23.9K is 15% above the market average of $20.8K, consistent with large-order contracts or value-added formulations.
4AHLCON PARENTERALS (INDIA) LIMITED
AHLCON PARENTERALS (INDIA) LIMITED is the fourth-largest Budesonide exporter from India, with a market share of 0.8% and a total export value of $1.6M across 22 shipments. Their average shipment value of $72.3K is above the market average of $20.8K, suggesting premium or bulk contract pricing.
AHLCON PARENTERALS (INDIA) LIMITED serves 3 named buyers in our database. M S I E MEDICA INC is the dominant customer, accounting for 57.3% of this supplier's tracked business. Top customers include:
• M S I E MEDICA INC — $911.0K across 13 shipments (57.3% of this supplier's total exports)
• M S I E MEDICA INC — $399.7K across 6 shipments (25.1% of this supplier's total exports)
• M S I E MEDICA INC — $280.1K across 4 shipments (17.6% of this supplier's total exports)
Key Insight: AHLCON PARENTERALS (INDIA) LIMITED's per-shipment value of $72.3K is 247% above the market average of $20.8K, consistent with large-order contracts or value-added formulations.
5AHLCON PARENTERALS INDIA LIMITED
AHLCON PARENTERALS INDIA LIMITED is the fifth-largest Budesonide exporter from India, with a market share of 0.6% and a total export value of $1.1M across 22 shipments. Their average shipment value of $49.2K is above the market average of $20.8K, suggesting premium or bulk contract pricing.
AHLCON PARENTERALS INDIA LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• M S I E MEDICA INC — $500.1K across 10 shipments (46.2% of this supplier's total exports)
• M S I E MEDICA INC — $277.9K across 6 shipments (25.7% of this supplier's total exports)
• I E MEDICA INC — $274.2K across 6 shipments (25.3% of this supplier's total exports)
• PHARMACEUTICAL TECHN — $20.4K across 0 shipments (1.9% of this supplier's total exports)
• PHARMACEUTICAL TECHN — $9.1K across 0 shipments (0.8% of this supplier's total exports)
Key Insight: AHLCON PARENTERALS INDIA LIMITED's per-shipment value of $49.2K is 136% above the market average of $20.8K, consistent with large-order contracts or value-added formulations.
6AXA PARENTERALS LIMITED
AXA PARENTERALS LIMITED is the fifth-largest Budesonide exporter from India, with a market share of 0.4% and a total export value of $753.8K across 43 shipments. Their average shipment value of $17.5K is below the market average of $20.8K, reflecting a high-volume, competitive pricing strategy.
AXA PARENTERALS LIMITED serves 5 named buyers in our database. TO THE ORDER OF PURC is the dominant customer, accounting for 65.7% of this supplier's tracked business. Top customers include:
• TO THE ORDER OF PURC — $495.3K across 28 shipments (65.7% of this supplier's total exports)
• TO THE ORDER — $104.7K across 6 shipments (13.9% of this supplier's total exports)
• DROGUERIA AVICENNA S — $59.5K across 3 shipments (7.9% of this supplier's total exports)
• TO THE ORDER OF — $58.3K across 3 shipments (7.7% of this supplier's total exports)
• To The Order — $36.0K across 2 shipments (4.8% of this supplier's total exports)
Key Insight: AXA PARENTERALS LIMITED operates with high shipment frequency (43 shipments) at a per-shipment value of $17.5K, indicating a broad distribution network with many smaller, regular orders.
From Indian Factories to Global Pharmacies — How Budesonide Flows
Once Budesonide leaves the manufacturing plants of companies like CIPLA LIMITED and SUN PHARMACEUTICAL INDUSTRIES LIMITED, it travels to 5 destination markets with a combined import value of $190.5M. United States absorbs the largest share at 55.0% ($104.8M), followed by Saudi Arabia (15.2%) and United Arab Emirates (8.0%).
In United States — the top destination — named importers include CIPLA USA INC UPS SUPPLY CHAIN SOLU, CIPLA USA INC UPS SUPPLY CHAIN SOL, EXELAN PHARMACEUTICALS, INC.
This geographic spread reflects Budesonide's role as an essential active pharmaceutical ingredient (API) and finished dosage form — sourced primarily from India due to its cost-competitive, WHO-compliant manufacturing base. The Sankey diagram below maps these destination countries to their named importers in detail.
🌍 Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Where Does Budesonide Go? Top Importing Countries & Their Buyers
Trade flow of Budesonide exports from India — top destination countries and the named companies importing it
Geographic Market Flow Analysis
Top Countries → Global Importers
Market Analysis: Top Importing Countries & Their Importers
1United States
United States ranks as the first-largest destination for Budesonide imports from India, with a total trade value of $104.8M across 488 shipments — representing a 55.0% share of all Budesonide exports. The average shipment value of $214.7K is above the global average of $20.8K, indicating high-value procurement contracts or branded formulations. This market is served by 7 tracked buyers.
Named Budesonide importers in United States: CIPLA USA INC UPS SUPPLY CHAIN SOLU is the largest buyer, accounting for 82.5% ($86.4M) of this market's total imports.
• CIPLA USA INC UPS SUPPLY CHAIN SOLU — $86.4M (82.5% of United States's total)
• CIPLA USA INC UPS SUPPLY CHAIN SOL — $4.6M (4.4% of United States's total)
• EXELAN PHARMACEUTICALS, INC — $3.9M (3.7% of United States's total)
Key Insight: United States's per-shipment average of $214.7K (930% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
United States is a key market for Budesonide imports from India.
2Saudi Arabia
Saudi Arabia ranks as the second-largest destination for Budesonide imports from India, with a total trade value of $28.9M across 0 shipments — representing a 15.2% share of all Budesonide exports. The average shipment value of $28.9M is above the global average of $20.8K, indicating high-value procurement contracts or branded formulations.
Key Insight: Saudi Arabia's per-shipment average of $28.9M (138457% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Saudi Arabia is a key market for Budesonide imports from India.
3United Arab Emirates
United Arab Emirates ranks as the third-largest destination for Budesonide imports from India, with a total trade value of $15.2M across 47 shipments — representing a 8.0% share of all Budesonide exports. The average shipment value of $323.9K is above the global average of $20.8K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Budesonide importers in United Arab Emirates: ACINO PHARMACEUTICALS FZ LLC is the largest buyer, accounting for 85.0% ($12.9M) of this market's total imports.
• ACINO PHARMACEUTICALS FZ LLC — $12.9M (85.0% of United Arab Emirates's total)
Key Insight: United Arab Emirates's per-shipment average of $323.9K (1455% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
United Arab Emirates is a key market for Budesonide imports from India.
4Algeria
Algeria ranks as the fourth-largest destination for Budesonide imports from India, with a total trade value of $13.2M across 98 shipments — representing a 6.9% share of all Budesonide exports. The average shipment value of $134.3K is above the global average of $20.8K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.
Named Budesonide importers in Algeria: BIOPHARM DISTRIBUTION SPA is the largest buyer, accounting for 62.8% ($8.3M) of this market's total imports.
• BIOPHARM DISTRIBUTION SPA — $8.3M (62.8% of Algeria's total)
• BIOPHARM DISTRIBUTION SPA, — $2.7M (20.2% of Algeria's total)
Key Insight: Algeria's per-shipment average of $134.3K (545% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Algeria is a key market for Budesonide imports from India.
5Philippines
Philippines ranks as the fifth-largest destination for Budesonide imports from India, with a total trade value of $4.0M across 6 shipments — representing a 2.1% share of all Budesonide exports. The average shipment value of $664.8K is above the global average of $20.8K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Budesonide importers in Philippines: M/S I.E. MEDICA INC., is the largest buyer, accounting for 22.8% ($911.0K) of this market's total imports.
• M/S I.E. MEDICA INC., — $911.0K (22.8% of Philippines's total)
Key Insight: Philippines's per-shipment average of $664.8K (3091% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Philippines is a key market for Budesonide imports from India.
People Also Ask — Budesonide Supplier & Trade Network
Who are the top suppliers of Budesonide from India?+
Which companies buy Budesonide from Indian manufacturers?+
Where does Budesonide exported from India go?+
What is the market share of the top Budesonide supplier from India?+
What is the average shipment value for Budesonide exports from India?+
Is Budesonide manufactured in India and exported globally?+
Which country imports the most Budesonide from India?+
Who are the buyers of Budesonide in Saudi Arabia?+
How concentrated is the Budesonide supplier market in India?+
How do I find verified buyers for Budesonide in specific countries?+
Budesonide Trade Network — Key Takeaways
- 1CIPLA LIMITED is India's dominant Budesonide exporter with a 65.8% market share and $125.4M in total exports — making it the single most important sourcing entity in this market.
- 2The top 275 suppliers collectively account for 71.9% of all tracked Budesonide exports, with a combined trade value of $190.5M.
- 3United States is the largest destination market, absorbing 55.0% of India's Budesonide exports ($104.8M). Saudi Arabia (15.2%) and United Arab Emirates (8.0%) follow.
- 4With 9.1K total shipments averaging $20.8K each, the Budesonide export trade from India reflects both bulk API supply and finished dosage form distribution.
- 5Verified buyers across the network include CIPLA USA INC UPS SUPPLY CHAIN SOL, ACINO PHARMACEUTICALS FZ LLC, SUN PHARMACEUTICAL INDUSTRIES,INC.., SUN PHARMACEUTICAL INDUSTRIES,INC.. — representing a diverse base of pharmaceutical importers, distributors, and generic drug manufacturers globally.
Network Overview
Supplier Network
Country Network
Network Insights
Top supplier: 5 customers
6 suppliers → 115 countries
Network value: $190.5M
Related Analysis
Market Intelligence
Latest developments and market context
Detailed market intelligence for Budesonide — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Budesonide.
- 2.Flow Mapping: 275 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
- 3.Value Aggregation: Trade value per supplier-buyer link aggregated from 9,145 individual shipment records. Values are FOB in USD.
- 4.Geographic Clustering: Buyer networks clustered across 115 destination countries to identify geographic concentration patterns.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
9,145 Verified Shipments
275 manufacturers in network
Expert-Reviewed
By pharmaceutical trade specialists